In August 2016, our co–principal investigator Michael Lederman published a reflection on HIV cure research in Pathogens and Immunity, the publication he launched in 2015. Dr. Lederman will present some of these thoughts on Monday, October 9 as we host Timothy Ray Brown, the first and only person ever cured of HIV. Find details of the event at www.clevelandhiv.org/trb and on Facebook.
A Cure for HIV Infection: “Not in My Lifetime” or “Just Around the Corner”?
Abstract: With the advent and stunning success of combination antiretroviral therapy (ART) to prolong and improve quality of life for persons with HIV infection, HIV research has been afforded the opportunity to pivot towards studies aimed at finding “a cure.” The mere idea that cure of HIV might be possible has energized researchers and the community towards achieving this goal. Funding agencies, both governmental and private, have targeted HIV cure as a high priority; many in the field have responded to these initiatives and the cure research agenda is robust.
In this “salon” two editors of Pathogens and Immunity, Michael Lederman and Daniel Douek ask whether curing HIV is a realistic, scalable objective. We start with an overview perspective and have asked a number of prominent HIV researchers to add to the discussion.
Find the full article here.